Home / Products / Cancer (Tumor) Cell Lines / KYSE-140
KYSE-140
Datasheet Protocol

KYSE-140

Cat. No. ARC0419
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Esophagus

Growth Properties:

Adherent

In stock
$1,500.00 / Vial
Ask a Question

Short Description 🔒

KYSE-140 is a cancer cell line of esophagus squamous cell carcinoma, isolated from in situ; esophagus.
 
Synonym: KYSE 140; KYSE140; Kyse140

Recommended Products

BBS2 Knockout HAP1 Polyclonal Cells BBS2 Knockout HAP1 Polyclonal Cells Cat. No. ARG22054 MFSD8 Knockout HT29 Polyclonal Cells MFSD8 Knockout HT29 Polyclonal Cells Cat. No. ARG14188 ERLIN1 Knockout jurkat Polyclonal Cells ERLIN1 Knockout jurkat Polyclonal Cells Cat. No. ARG13554 ITGA2 Knockout Raji Polyclonal Cells ITGA2 Knockout Raji Polyclonal Cells Cat. No. ARG23838 CCDC106 Knockout Hela Polyclonal Cells CCDC106 Knockout Hela Polyclonal Cells Cat. No. ARG42882 ERN1 Knockout 786O Polyclonal Cells ERN1 Knockout 786O Polyclonal Cells Cat. No. ARG4788
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Esophagus
Disease:
Squamous cell carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
54 years
Derived From Site:
In situ; Esophagus
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

LIMA1 Knockout A549 Polyclonal Cells

LIMA1 Knockout A549 Polyclonal Cells

Cat. No. ARG11117
 WASF2 Knockout U2OS Cell Line

WASF2 Knockout U2OS Cell Line

Cat. No. ARG44217
 CHID1 Knockout jurkat Polyclonal Cells

CHID1 Knockout jurkat Polyclonal Cells

Cat. No. ARG12928
 AAMDC Knockout NCI-H1299 Polyclonal Cells

AAMDC Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG30169
 ATF3 Knockout HEK293T Polyclonal Cells

ATF3 Knockout HEK293T Polyclonal Cells

Cat. No. ARG37807
 MSRA Knockout Hela Polyclonal Cells

MSRA Knockout Hela Polyclonal Cells

Cat. No. ARG7800